FDA-Approved MedicationUpdated November 2026

Ozempic Guide

Ozempic is Novo Nordisk's brand of semaglutide for type 2 diabetes. It comes as a once-weekly injection (0.25 mg to start, then 0.5, 1 or 2 mg) and, since May 4, 2026, as Ozempic tablets taken once a day (1.5, 4 or 9 mg), which replace Rybelsus in the US. It is widely prescribed off-label for weight loss. The injection's label also names two protective uses in type 2 diabetes: fewer major heart events in people who already have heart disease, and slower loss of kidney function, with fewer kidney failures and cardiovascular deaths, in people with chronic kidney disease. The tablets carry the heart-event use, for adults at high risk, but not the kidney one.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

At a Glance

Ozempic at a glance
Generic NameSemaglutide
Brand NamesOzempic
FDA StatusInjection: FDA-approved for glycemic control in type 2 diabetes (December 2017), to reduce major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease (2020), and to reduce kidney function decline, kidney failure and cardiovascular death in adults with type 2 diabetes and chronic kidney disease (January 2025). Ozempic tablets, taken once daily and on sale since May 4, 2026, share Rybelsus's label: glycemic control in adults with type 2 diabetes and fewer major cardiovascular events in those at high risk. Weight loss is off-label use.[1]
Approval DateDecember 5, 2017[1]

Ozempic also comes as a pill. Ozempic tablets, taken once a day at 1.5, 4 or 9 mg, went on sale on May 4, 2026 and replace Rybelsus in the US. Our guide to Ozempic tablets covers the doses, the empty-stomach rule and the price. If you take Rybelsus now, the article on why Rybelsus is being discontinued explains how its doses map onto the new tablets.

How does Ozempic work?

Ozempic activates GLP-1 receptors to stimulate glucose-dependent insulin secretion, suppress glucagon, and reduce blood sugar levels. The same mechanism that controls blood glucose also suppresses appetite and slows gastric emptying, producing significant weight loss as a secondary effect. At 1–2mg doses, Ozempic delivers strong appetite suppression comparable to Wegovy's lower dose range.[2][3]

Dosing Schedule — Injection

Ozempic uses a gradual dose escalation to minimize side effects. Always follow your prescriber's guidance and the current FDA label[1].

Weeks 1–40.25mg/week
Weeks 5+0.5mg/week
After 4+ weeks at 0.5mg1mg/week (if needed)
After 4+ weeks at 1mg2mg/week (max)

Dosing Schedule — Ozempic tablets

Days 1–301.5mg/day (starter dose)
Days 31–604mg/day
Day 61+4mg/day, or 9mg/day if more glycemic control is needed

What side effects does Ozempic cause?

Common: nausea, vomiting, diarrhea, stomach pain, constipation. Injection site reactions are common in early weeks. Serious (rare): pancreatitis, diabetic retinopathy worsening, kidney injury, hypoglycemia when combined with sulfonylureas or insulin. Thyroid C-cell tumor risk noted in animal studies.[1][2]

Nothing above is the full list. Your prescriber can give you the complete safety picture, and every adverse reaction on record sits in the current FDA prescribing information[1].

Clinical Trial Results

In the SUSTAIN-6 cardiovascular trial, Ozempic reduced the risk of major cardiovascular events by 26% vs. placebo (Marso et al. NEJM 2016, PMID 27633186). For weight loss specifically, the STEP-8 head-to-head trial (Rubino et al. JAMA 2022, PMID 35015037) used semaglutide 2.4 mg — the Wegovy dose, not the Ozempic 1 mg dose — and showed 15.8% weight loss vs 6.4% for liraglutide 3 mg. The approvals do not overlap: type 2 diabetes is the whole of Ozempic's label, and chronic weight management belongs to Wegovy, the other semaglutide.[2]

Source: Published clinical trial data (STEP / SURMOUNT trial series) — see the Sources panel below for full citations.

Where can you get Ozempic?

Sellers in our register that will dispense semaglutide, or a compounded version of it, after an online consultation — shipped to your door.

8.8/ 10
Verified partner

altRX

Best for: compounded semaglutide from $89/month at the same price at every dose

★★★★☆8.8/10

Editorial score · methodology

$1,149/mo
BrandSemaglutideLegitScript Verified
Get StartedRead full altRX review →
8.5/ 10
Verified partner

Gala

Best for: moving between compounded and brand without changing seller

★★★★☆8.5/10

Editorial score · methodology

$1,299/mo
BrandSemaglutideLegitScript Verified
Get StartedRead full Gala review →
8.1/ 10
Verified partner

Sesame Care

Best for: oral orforglipron alongside the injectables

★★★★☆8.1/10

Editorial score · methodology

$349/mo+ care fee
BrandSemaglutide
Get StartedRead full Sesame Care review →
7.9/ 10
Verified partner

RxSpan MD

Best for: knowing which pharmacy fills the vial: it names Belmar Pharmacy

★★★★☆7.9/10

Editorial score · methodology

$1,299/mo
BrandSemaglutideGlutathioneNAD+SermorelinLegitScript Verified
Get StartedRead full RxSpan MD review →
7.9/ 10
Verified partner

Luvo Health

Best for: moving between compounded and brand without changing seller

★★★★☆7.9/10

Editorial score · methodology

$1,299/mo
BrandSemaglutideGonadorelinNAD+SermorelinLegitScript Verified
Get StartedRead full Luvo Health review →
7.4/ 10
Verified partner

Wellorithm

Best for: compounded semaglutide at a flat $247 every 28 days, any dose

★★★★☆7.4/10

Editorial score · methodology

$1,199/moprepaid
BrandSemaglutide
Get StartedRead full Wellorithm review →

43 sellers in the register publish a price; the lowest starts at $149 a month, checked November 2026. What each one charges to start, cheapest at the top. Compounded semaglutide from state-licensed 503A pharmacies is legal under federal compounding law when made for an individual patient[4], and the rules loosen further, to include bulk compounding by 503B outsourcing facilities, only while a molecule sits on the FDA Drug Shortage List[5]. An FSA or HSA will generally cover either kind of prescription, compounded or branded, under IRS Publication 502[6]. What you actually pay moves with your dose and with whatever promotion happens to be running.

Starting Ozempic price per seller, cheapest first. Prices in USD per month; checked November 2026.
ProviderStarting PriceLink
NovoCare Pharmacy$149/moVisit
Mochi Health$199/mo + membershipVisit
GOAL.MD$244/moVisit
Knownwell$349/mo + visit feeVisit
Sesame Care$349/mo + care feeVisit
Maximus$349.99/moVisit
Synergy Rx$499/moVisit
Care Bare Rx$705/moVisit
Vital Edge$705/moVisit
altRX$1,149/moVisit
Show all 43 Ozempic sellers
Ozempic sellers 11 to 43, cheapest first. Prices in USD per month.
Wellya$1,149/moVisit
NoBsRx$1,199/moVisit
Wellorithm$1,199/mo, prepaidVisit
Astra$1,200/moVisit
Oak$1,250/moVisit
Aquivia Health$1,299/moVisit
Gala$1,299/moVisit
Josie$1,299/moVisit
Luvo Health$1,299/moVisit
Pallas Health$1,299/moVisit
Peptivo$1,299/moVisit
Remmy$1,299/moVisit
RxSpan MD$1,299/moVisit
Trimrose$1,299/moVisit
TrimRx$1,299/moVisit
Tryozi$1,299/moVisit
VivioMD$1,299/moVisit
XMD Wellness$1,299/moVisit
Effecty$1,300/moVisit
AlyveRx$1,395/moVisit
Elevated Health$1,399/moVisit
Eve$1,399/moVisit
Layla$1,399/moVisit
WellMedRx$1,399/moVisit
SkinnyRx$1,400/moVisit
myRocky$1,409/mo + program feeVisit
Fridays$1,498/moVisit
Nucific$1,498/moVisit
NuuVim$1,498/moVisit
Corsica Health$1,499/moVisit
Good Girl Rx$1,580/moVisit
DudeMeds$1,585/moVisit
Concierge MD LA$1,999/moVisit

Short verdict pages setting Ozempic against the other GLP-1 options, working from the trial results, the dose ladders on each label, and what the manufacturers charge today.

See all drug-vs-drug verdicts.

The trials that produced the Ozempic label, taken endpoint by endpoint, with the figures read off the source.

Questions people actually asked about Ozempic in named subreddits, each answered from the published trial data.

One-screen references for the dose schedule, what to do about a missed dose, and the side effects that warrant a call. Every figure checked against the DailyMed label.

The peer-reviewed studies on Ozempic and its neighbours that carry the most weight, gathered into lists. Every PMID was checked against PubMed esummary rather than recalled.

Longer pieces written here, built on the trial papers themselves, checked against the FDA label, and argued rather than summarized.

503A vs 503B Compounding Pharmacies: Who Oversees Your Compounded GLP-1
A 503A pharmacy compounds per patient under a state board. A 503B outsourcing facility registers with FDA, follows CGMP, is inspected and must report adverse events. What each means for compounded GLP-1s, and how to check yours.
10 min read12 citations
The Head-to-Head, and What It Settles
751 adults randomized to tirzepatide or semaglutide, each at maximum tolerated dose, for 72 weeks. Tirzepatide produced 20.2% weight loss against 13.7%, and on several other endpoints the answer runs the other way.
7 min read3 citations
Many People Never Reach the Dose
Only 58% of people starting semaglutide reached the recommended maintenance dose after four weeks, and 21% stayed on the starting dose. More than half of oral semaglutide starters stopped altogether.
6 min read1 citation
Switching Between GLP-1 Drugs
No label contains a dose equivalence between semaglutide and tirzepatide, because no regulator has been asked to approve one. Every conversion chart online is somebody's arithmetic.
5 min read3 citations
Does Your GLP-1 Wear Off Before the Next Dose?
Half of each dose is still present when the next one is due. The label puts semaglutide's elimination half-life at roughly seven days, tirzepatide's at about five. That is a slope, not a cliff.
6 min read2 citations
GLP-1 Drugs and Type 1 Diabetes: The Label Says Unevaluated. Three Trials Disagree.
36% of people with type 1 diabetes and obesity hit a composite of time-in-range, low-glucose safety and 5% weight loss, against 0% on placebo. Total daily insulin fell about a third in a second trial.
7 min read9 citations

Frequently Asked Questions

Injection: FDA-approved for glycemic control in type 2 diabetes (December 2017), to reduce major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease (2020), and to reduce kidney function decline, kidney failure and cardiovascular death in adults with type 2 diabetes and chronic kidney disease (January 2025). Ozempic tablets, taken once daily and on sale since May 4, 2026, share Rybelsus's label: glycemic control in adults with type 2 diabetes and fewer major cardiovascular events in those at high risk. Weight loss is off-label use.
What you pay for Ozempic turns on who is selling it and in what form. Uninsured, the branded product runs roughly $1,000 to $1,600 a month; compounded versions through telehealth sellers usually land between $129 and $400. The table above carries the current figures from our register. Before you commit, check whether a manufacturer savings program applies to you.
Common: nausea, vomiting, diarrhea, stomach pain, constipation. Injection site reactions are common in early weeks. Serious (rare): pancreatitis, diabetic retinopathy worsening, kidney injury, hypoglycemia when combined with sulfonylureas or insulin. Thyroid C-cell tumor risk noted in animal studies.
Ozempic is prescription-only, so someone licensed has to write it — your own doctor, an endocrinologist, or one of the telehealth sellers above. For compounded versions the telehealth route is usually both quicker and cheaper out of pocket than a traditional pharmacy.
Sources & methodology — as of November 2026
  1. 1.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  2. 2.SUSTAIN-6 Trial — Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (Marso SP et al.)— New England Journal of Medicine.PMID: 27633186.
  3. 3.ADA — Standards of Care in Diabetes (2025)— American Diabetes Association.
  4. 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  5. 5.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  6. 6.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.

Glossary

The words sellers use, defined. Tap any term.